Equities Analysts Offer Predictions for BCRX Q2 Earnings
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Analysts at HC Wainwright boosted their Q2 2025 earnings per share (EPS) estimates for shares of BioCryst Pharmaceuticals in a research report issued on Tuesday, May 6th. HC Wainwright analyst A. Fein now forecasts that the biotechnology company will post earnings of $0.10 per share for the […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Analysts at HC Wainwright boosted their Q2 2025 earnings per share (EPS) estimates for shares of BioCryst Pharmaceuticals in a research report issued on Tuesday, May 6th. HC Wainwright analyst A. Fein now forecasts that the biotechnology company will post earnings of $0.10 per share for the […]
